Absci Corp(us:ABSI)

2.40

-4.38%

Updated on 2025-04-02

Open:2.52
Close:2.40
High:2.53
Low:2.34
Prev Close:2.51
Volume:4.04M
Turnover:9.75M
Turnover Ratio:3.17%
Shares:127.35M
MarketCap:305.65M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3011990.00%000
2024-03-311186046161253.51%522920
2023-12-31803371378536.22%202127
2023-09-30773379196036.36%91733
2023-06-30923411411036.84%182141
2023-03-31844035402843.63%92232
2022-12-31914181159545.25%162531
2022-09-30854396522147.33%132227
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Fmr Llc1481045413.11%9489336.85%
2024-03-31Redmile Group, Llc82533167.30%2222222.77%
2024-03-31Fred Alger Management, Llc74078096.56%7407809
2024-03-31Vanguard Group Inc34452723.05%86913133.74%
2024-03-31Ark Investment Management Llc32770942.90%3277094
2024-03-31Millennium Management Llc17699941.57%1242254235.39%
2024-03-31Marshall Wace, Llp14868231.32%1252881535.55%
2024-03-31Woodline Partners Lp14741851.30%1474185
2024-03-31Laurion Capital Management Lp11864271.05%1072573942.06%
2024-03-31Affinity Asset Advisors, Llc10250000.91%1025000

About

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Address:18105 SE Mill Plain Boulevard

Market Movers